Skip to content

10th June 2024

MedTech Innovator reveals 65 startups within 2024 Accelerator Cohort

“Having evaluated thousands of applicants since November, I can tell you definitively that the 2024 MedTech Innovator Cohort represents the best emerging startups around the globe.”

– Paul Grand, CEO and Founder, MedTech Innovator

How does a startup distinguish itself in the fiercely competitive world of medical technology? What impact does joining the elite 2024 MedTech Innovator Cohort have on its future prospects? Let’s talk about MedTech Innovator’s Thursday announcement, revealing the 65 companies that are making up its 2024 Accelerator Cohort.

The 2024 Accelerator Cohort

MedTech Innovator revealed its 2024 Accelerator Cohort on Thursday, selecting 65 startups from a competitive pool with a 5% acceptance rate. These companies will gain unparalleled access to industry experts, investors, and healthcare leaders in the four-month program, enhancing their visibility and growth prospects.

At the end of the MTI accelerator program, cohort companies will compete for audience votes at top industry conferences, vying for $800,000 in non-dilutive funding.

“Our accelerator has become the gold standard, thanks to our industry-leading track record of identifying and refining the most innovative medtech startups in the world,”

stated Paul Grand, CEO and Founder of MedTech Innovator. 

Grand illustrated how, since the launch of MedTech Innovator, its over 600 graduates have achieved 310 FDA approvals and secured $8 billion in follow-on funding. He emphasised that after evaluating thousands of applicants, the 2024 cohort stands out as the best emerging startups globally.

“We are excited to spend the next four months with our industry-leading corporate partners and industry experts, to help these entrepreneurs advance their medical device, diagnostic and digital health innovations to improve the lives of millions.”

Some statistics on the Cohort

For the 2024 Accelerator, approximately 1,300 companies applied, with 15% (192) advancing to MedTech Innovator’s Road Tour in Los Angeles, Washington, D.C., and Dublin, Ireland. 

In these locations, startups received feedback from over 300 industry experts. Based on these evaluations, MTI’s strategic partners, including Asahi Intecc, BD, Dexcom, Edwards Lifesciences, Johnson & Johnson, NIPRO, Olympus, W. L. Gore & Associates, and Zimmer Biomet, selected 65 companies for the cohort, representing 14 U.S. states and 16 countries.

This year’s accelerator includes: 

  • 5 companies in the MTI/ASPS Plastic Surgery Accelerator;
  • 5 in the Heart and Brain Health Accelerator with the American Heart Association;
  • 5 in the Military Medicine track.

These opportunities involve the Medical Technology Enterprise Consortium, where each company will be receiving specialised mentorship and additional event opportunities.

Paul Grand: CEO | Founder | Mentor 

Paul Grand, CEO of MedTech Innovator, leads a venture funded by 35 corporate partners, nonprofits, and federal agencies, with the goal to identify and support promising medtech and biotools startups worldwide. 

Grand founded MedTech Innovator within RCT Ventures in 2013, later making it independent with RCT’s support in 2016. Before RCT, he founded and led eight life sciences and technology firms, including Imagine Pharmaceuticals, focused on blood-brain barrier drug delivery, and MicroSurgeon, specialising in thermal tumour ablation devices.

Deeply engaged in fostering healthcare innovation, Grand mentors students at prestigious universities like UCLA, Stanford, USC, and UCSF, and advises on investment for LARTA NIH Commercialization Assistance Program. He also serves on Oversight Committees for Coulter Translational Research Partnership Programs and reviews funding programs for several universities. Additionally, he’s a frequent speaker at healthcare conferences and media expert.

About MedTech Innovator

MedTech Innovator, headquartered in Los Angeles, California, since its inception in 2013, stands as a global nonprofit competition and the world’s largest accelerator for medical device, digital health, and diagnostic companies. 

Their goal is to enhance patient lives by nurturing companies driving healthcare transformation. Graduates have launched 300+ products, securing $7.6B in follow-on funding and impacting numerous lives.

Ready to discuss the future of healthcare?

Join us at MedTech Malta from November 6th to 8th! 

Against the vibrant backdrop of Malta, our event gathers MedTech innovators, investors, and leaders for dynamic panel discussions, CEO workshops, and cutting-edge technology showcases. Following last year’s success, we’re back for more groundbreaking innovation.

At MedTech World, we deeply understand the transformative impact startups have, driving our commitment to providing unwavering assistance. So come network, pitch your ideas, and attend the prestigious MedTech Malta Awards Gala.

Don’t miss this opportunity to shape the future of healthcare! Secure your tickets now and be part of the revolution.

For more insightful perspectives, overviews, and the latest MedTech news, don’t forget to bookmark our newspage, subscribe to our YouTube Channel, and sign up for our Newsletter!